No photo of Naomi Fujioka
Contact Expert

View Scopus Profile

Naomi Fujioka

20102023

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 14 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients with Recurrent Small Cell LungCancer: Big Ten Cancer Research Consortium BTCRC-LUN17-127

Fujioka, N.

BIG TEN CANCER RESEARCH CONSORTIUM

8/30/18 → 8/30/23

Project: Research project

    • A Phase 1b/2a, Multi-Center Open-Label Study to Evaluate the Safety and Efficacy of CombinationTreatment with MEDI0457 (INO-3112) and Durvalumab (MEDI4736) in Patients with Recurrent / MetastaticHuman Papilloma Virus Associated Head and Neck Squamous

    Fujioka, N.

    AstraZeneca

    5/16/18 → 5/30/23

    Project: Research project

    • Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab alonefollowing Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer(NSCLC)

    Fujioka, N.

    BIG TEN CANCER RESEARCH CONSORTIUM

    1/1/18 → 1/31/21

    Project: Research project

    • A Phase II Trial of Chemotherapy plus Pembrolizumab in patients with advanced NSCLC previously treatedwith PD-1 or PD-L1 Inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029

    Fujioka, N.

    BIG TEN CANCER RESEARCH CONSORTIUM

    12/1/17 → 11/30/22

    Project: Research project

    • Determination of Protein Requirements Using a Stable Iso

    Earthman, C. P., Fujioka, N., Patel, M. R., Vock, D. M. & Price, K. L.

    NUTRICIA RESEARCH FOUNDATION

    1/1/16 → 8/31/20

    Project: Research project

    • Research Output

    Detection and quantification of 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) from smoker albumin and its potential as a surrogate biomarker of tobacco-specific nitrosamines exposure and bioactivation

    Wang, Y., Narayanapillai, S. C., Hu, Q., Fujioka, N. & Xing, C., Sep 1 2019, In : Toxicology Letters. 311, p. 11-16 6 p.

    Research output: Contribution to journal › Article

    • Immune Checkpoint Inhibitors in ROS1-Rearranged Non–Small Cell Lung Cancer: A Report of Two Cases

    Jain, A., Fujioka, N. & Patel, M., Aug 2019, In : Journal of Thoracic Oncology. 14, 8, p. e165-e167

    Research output: Contribution to journal › Letter

    2 Scopus citations

    A stable isotope dilution tandem mass spectrometry method of major kavalactones and its applications

    Wang, Y., Eans, S. O., Stacy, H. M., Narayanapillai, S. C., Sharma, A., Fujioka, N., Haddad, L., McLaughlin, J., Avery, B. A. & Xing, C., May 2018, In : PloS one. 13, 5, e0197940.

    Research output: Contribution to journal › Article

    Open Access
    • 2 Scopus citations

    Contribution of Tobacco Use and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone to Three Methyl DNA Adducts in Urine

    Wang, Y., Narayanapillai, S., Hu, Q., Fujioka, N. & Xing, C., Sep 17 2018, In : Chemical research in toxicology. 31, 9, p. 836-838 3 p.

    Research output: Contribution to journal › Article

    • 4 Scopus citations

    Identification and analysis of a mercapturic acid conjugate of indole-3-methyl isothiocyanate in the urine of humans who consumed cruciferous vegetables

    Upadhyaya, P., Zarth, A. T., Fujioka, N., Fritz, V. A. & Hecht, S. S., Jan 1 2018, In : Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 1072, p. 341-346 6 p.

    Research output: Contribution to journal › Article

    Open Access